http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011132259-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bdd619b8a2cc2f110b9ee4dc8d896a17
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-335
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D313-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-335
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
filingDate 2011-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccee43be06acbe1b9e845fc51177fb90
publicationDate 2011-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2011132259-A
titleOfInvention Ophthalmic antiallergic composition suitable for use in contact lenses
abstract An antiallergic effective amount of a drug selected from the group consisting of olopatadine and emedastine, which is a topically administrable multi-dose antiallergic composition suitable for use by a patient wearing a contact lens; To provide a composition comprising an ocularly acceptable polymeric quaternary ammonium compound as a preservative, provided that the composition does not comprise benzalkonium chloride. Topically administrable antiallergic compositions comprising olopatadine and polymeric quaternary ammonium preservatives are suitable for use by patients wearing contact lenses. [Selection figure] None
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015509933-A
priorityDate 2000-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226416763
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419587381
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393816
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559564
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281071
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536251
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8753
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425188129
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID223
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46878555
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448922993
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54675830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396615
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396616
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3219
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6144
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535285
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284599

Total number of triples: 46.